Cellebrite DI Ltd. (NASDAQ:CLBT) Q4 2025 Earnings Call Transcript February 11, 2026 Cellebrite DI Ltd. misses on earnings expectations. Reported EPS is $0.08 EPS, expectations were $0.14. Operator: ...
OncoRes Medical today announced it has closed an AUD $27M private funding round (?the Funding round') to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography ...
Royal Philips, together with Erasmus MC and a broad consortium of industry, academic, and patient partners, has secured funding from the EU’s Innovative Health Initiative to coordinate the five-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results